YOD1 serves as a potential prognostic biomarker for pancreatic cancer

BACKGROUND: Ubiquitination is a basic post-translational modification of intracellular proteins and can be reversed enzymatically by DUBs (deubiquitinating enzymes). More than 90 DUBs have been identified. Among them, the deubiquitinating enzyme YOD1, a member of the ovarian tumor domain protease (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhishuo, Zhao, Wenxia, Li, Yiming, Li, Yang, Cheng, Hanzeng, Zheng, Liyun, Sun, Xiaoyu, Liu, Hao, Shao, Rongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158148/
https://www.ncbi.nlm.nih.gov/pubmed/35642058
http://dx.doi.org/10.1186/s12935-022-02616-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158148/
https://www.ncbi.nlm.nih.gov/pubmed/35642058
http://dx.doi.org/10.1186/s12935-022-02616-9

Ejemplares similares